Two samples collected from the patient on (b)(6) 2015 were sent to the siemens site for investigation, along with 6 testpaks from lot 235173002, the lot that was used when the 0.23 ng/ml result was obtained.Investigation conclusion: internal testing confirmed that the discrepant patient samples returned from the customer were falsely elevated due to heterophile antibody interference.The initial result obtained on the stratus cs was 0.23 ng/ml and then, after sample treatment with a heterophilic antibody blocking reagent, a mean result of 0.03 ng/ml was obtained on the stratus cs.This verified that the elevated result was due to heterophilic antibody interference (nonspecific binding) with the stratus cs ctni assay.
|